← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fox Chase Cancer Center
Philadelphia, PA
$311,195,626
Total funding
321
Grants
Funding over time
peak $51.5M · FY2005–16$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$304,327,834 · 309
DOD$3,341,346 · 9
DOE$1,719,932 · 1
FDA$1,520,557 · 1
AHRQ$285,957 · 1
By mechanism
R01$136,801,608 · 86
P30$52,484,957 · 56
U01$28,780,323 · 10
P50$19,658,800 · 25
R21$11,235,164 · 32
U10$10,060,939 · 2
Investigators at Fox Chase Cancer Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Comprehensive Cancer Center Program at Fox Chase$8,241,288
P30 · FY2009 · CA
Comprehensive Cancer Center Program at Fox Chase$8,241,288
P30 · FY2010 · CA
Comprehensive Cancer Center Program at Fox Chase$8,151,999
P30 · FY2005 · CA
Comprehensive Cancer Center Program at Fox Chase$8,123,116
P30 · FY2006 · CA
Comprehensive Cancer Center Program at Fox Chase$8,028,491
P30 · FY2008 · CA
Addition and Expansion of Laboratory Animal Research Fa*$8,000,000
C06 · FY2009 · RR
COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE$7,951,999
P30 · FY2004 · CA
Comprehensive Cancer Center Program at Fox Chase$7,949,000
P30 · FY2007 · CA
COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE$7,730,174
P30 · FY2003 · CA
COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE$7,514,810
P30 · FY2002 · CA
COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE$7,135,664
P30 · FY2001 · CA
COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE$6,968,108
P30 · FY2000 · CA
Comprehensive Cancer Center Program at Fox Chase$4,061,662
P30 · FY2012 · CA
Comprehensive Cancer Center Program at Fox Chase$4,038,908
P30 · FY2011 · CA
SPORE IN OVARIAN CANCER$3,261,477
P50 · FY2002 · CA
SPORE IN OVARIAN CANCER$3,100,910
P50 · FY2003 · CA
SPORE IN OVARIAN CANCER$2,969,507
P50 · FY2001 · CA
SPORE in Ovarian Cancer$2,412,603
P50 · FY2005 · CA
Preclinical Efficacy and Intermediate Endpoint Assays$2,364,525
N01 · FY2008 · CA
SPORE in Ovarian Cancer$2,308,479
P50 · FY2006 · CA